ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Senior/Research Associate at NewLimit - ApplyBlast

Senior/Research Associate

NewLimit

1 month ago

South San Francisco, California, United States

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

NewLimit is seeking a Senior/Research Associate to join the Single Cell Technology and Assay Development group, focusing on developing and applying advanced molecular and bioanalytical technologies for therapeutic discovery. The role involves measuring the biodistribution and efficacy of reprogramming medicines, designing experiments for cell and tissue processing, and performing single-cell profiling to map epigenetic features of age-related diseases. This position supports the company's mission to extend human healthspan by treating age-related diseases through epigenetic reprogramming.

Responsibilities

Measure biodistribution and efficacy of reprogramming medicines using molecular assays and genomics methods
Design and execute experiments involving isolation and processing of cells, tissues, and organs for molecular profiling
Perform single cell profiling experiments to map epigenetic features of age-related disease and evaluate interventions

Skills

Qualifications

Bachelor's degree in cell biology, molecular biology, or a related natural science

About NewLimit

newlimit.com

Headquarters

South San Francisco, California, United States

Company Size

11-50 employees

Founded

2022

View Profile

NewLimit is a biotechnology company focused on extending human healthspan by unlocking regenerative potential. It builds therapies and platform technologies aimed at restoring youthful function to tissues and organs by targeting core cellular and molecular drivers of aging. NewLimit advances programs through preclinical research and collaborations to translate regenerative biology into treatments for age‑related disease. The company emphasizes translational science with the goal of delivering durable, clinically meaningful rejuvenation across organ systems.